CAS: 222631-44-9 - 3,4-Pyrrolidinediol,2-(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-(hydroxymethyl)-, hydrochloride(1:1), (2S,3S,4R,5R)-
Formel:C11H15N5O3・ClH
InChl:InChI=1S/C11H15N5O3.ClH/c12-11-8-6(14-3-15-11)4(1-13-8)7-10(19)9(18)5(2-17)16-7;/h1,3,5,7,9-10,13,16-19H,2H2,(H2,12,14,15);1H/t5-,7+,9-,10+;/m1./s1
InChI Key:InChIKey=PCCHVYNGFMEGIG-QPAIBFMUSA-N
SMILES:Cl.OCC1NC(C2=CNC=3C(=NC=NC32)N)C(O)C1O
- Synonyme:
- 3,4-Pyrrolidinediol, 2-(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-(hydroxymethyl)-, monohydrochloride, (2S,3S,4R,5R)-
- 3,4-Pyrrolidinediol,2-(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-(hydroxymethyl)-,monohydrochloride, (2S,3S,4R,5R)- (9CI)
- Bcx 4430
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
Galidesivir DiHCl REF: 4Z-G-195001CAS: | - - - | Nachfragen | Mi 08 Jan 25 | |
BCX 4430 REF: TR-B119190CAS: 222631-44-9 | - - - | 46.850,00 € | Di 18 Feb 25 | |
BCX 4430 hydrochloride REF: 3D-NB58350CAS: 222631-44-9 | Min. 95% | Nachfragen | Di 18 Feb 25 | |
Galidesivir hydrochloride REF: TM-T10491LCAS: 222631-44-9 | 98% | 1.818,00 €~3.810,00 € | Di 11 Mär 25 |
Galidesivir DiHCl
Ref: 4Z-G-195001
10mg | Nachfragen | ||
25mg | Nachfragen | ||
50mg | Nachfragen | ||
100mg | Nachfragen |
BCX 4430
Kontrolliertes ProduktRef: TR-B119190
10mg | 46.850,00 € |
BCX 4430 hydrochloride
Ref: 3D-NB58350
5mg | Nachfragen |
Galidesivir hydrochloride
Ref: TM-T10491L
25mg | 1.818,00 € | ||
50mg | 2.376,00 € | ||
100mg | 3.810,00 € |